Cargando…

Identification of Selective Small Molecule Inhibitors of the Nucleotide-Binding Oligomerization Domain 1 (NOD1) Signaling Pathway

NOD1 is an intracellular pattern recognition receptor that recognizes diaminopimelic acid (DAP), a peptidoglycan component in gram negative bacteria. Upon ligand binding, NOD1 assembles with receptor-interacting protein (RIP)-2 kinase and initiates a signaling cascade leading to the production of pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rickard, David J., Sehon, Clark A., Kasparcova, Viera, Kallal, Lorena A., Haile, Pamela A., Zeng, Xin, Montoute, Monica N., Poore, Derek D., Li, Hu, Wu, Zining, Eidam, Patrick M., Emery, John G., Marquis, Robert W., Gough, Peter J., Bertin, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013053/ https://www.ncbi.nlm.nih.gov/pubmed/24806487 http://dx.doi.org/10.1371/journal.pone.0096737

Ejemplares similares

Identification of Benzimidazole Diamides as Selective Inhibitors of the Nucleotide-Binding Oligomerization Domain 2 (NOD2) Signaling Pathway
por: Rickard, David J., et al.
Publicado: (2013)

A Key Role for the Endothelium in NOD1 Mediated Vascular Inflammation: Comparison to TLR4 Responses
por: Gatheral, Timothy, et al.
Publicado: (2012)

Characterization of Rabbit Nucleotide-Binding Oligomerization Domain 1 (NOD1) and the Role of NOD1 Signaling Pathway during Bacterial Infection
por: Guo, Mengjiao, et al.
Publicado: (2017)

Role of nucleotide‐binding oligomerization domain 1 (NOD1) in pericyte‐mediated vascular inflammation
por: Navarro, Rocío, et al.
Publicado: (2016)

Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis
por: Vlacil, Ann-Kathrin, et al.
Publicado: (2020)

Nucleotide-Binding Oligomerization Domain 1 (NOD1) Positively Regulates Neuroinflammation during Japanese Encephalitis Virus Infection
por: Chen, Zheng, et al.
Publicado: (2022)

Role of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of Atherosclerosis
por: Kim, Ha-Jeong
Publicado: (2015)

MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses
por: Yu, Jong W., et al.
Publicado: (2015)

The nucleotide-binding oligomerization domain-containing protein 1 (NOD1) polymorphism S7N does not affect receptor function
por: Mayle, Sophie, et al.
Publicado: (2014)

Nucleotide-oligomerizing domain-1 (NOD1) receptor activation induces pro-inflammatory responses and autophagy in human alveolar macrophages
por: Juárez, Esmeralda, et al.
Publicado: (2014)

Expression of Nucleotide-oligomerization Domain (NOD) and Related Genes in Mouse Tissues Infected with Mycobacterium leprae
por: Kim, Tae Hoon, et al.
Publicado: (2015)

Engagement of Nucleotide-binding Oligomerization Domain-containing Protein 1 (NOD1) by Receptor-interacting Protein 2 (RIP2) Is Insufficient for Signal Transduction
por: Mayle, Sophie, et al.
Publicado: (2014)

Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia
por: Hommes, Tijmen J., et al.
Publicado: (2015)

Cyclosporine A Impairs Nucleotide Binding Oligomerization Domain (Nod1)-Mediated Innate Antibacterial Renal Defenses in Mice and Human Transplant Recipients
por: Tourneur, Emilie, et al.
Publicado: (2013)

p62/SQSTM1 Enhances NOD2-Mediated Signaling and Cytokine Production through Stabilizing NOD2 Oligomerization
por: Park, Sangwook, et al.
Publicado: (2013)

Pathogen Sensing by Nucleotide-binding Oligomerization Domain-containing Protein 2 (NOD2) Is Mediated by Direct Binding to Muramyl Dipeptide and ATP
por: Mo, Jinyao, et al.
Publicado: (2012)

Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders
por: WATANABE, Tomohiro, et al.
Publicado: (2017)

Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand caucasian population: a case-control study
por: Huebner, Claudia, et al.
Publicado: (2009)

Activation of Nucleotide Oligomerization Domain 2 (NOD2) by Human Cytomegalovirus Initiates Innate Immune Responses and Restricts Virus Replication
por: Kapoor, Arun, et al.
Publicado: (2014)

511 Role of NLR (Nucleotide Oligomerization Domain (NOD)—like Receptor) on Allergic Inflammation in a Mouse Model of Allergic Rhinitis
por: Kim, Soo Whan, et al.
Publicado: (2012)

Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer
por: Harris, Philip A., et al.
Publicado: (2019)

Protective Role of Rabbit Nucleotide-Binding Oligomerization Domain-2 (NOD2)-Mediated Signaling Pathway in Resistance to Enterohemorrhagic Escherichia coli Infection
por: Guo, Mengjiao, et al.
Publicado: (2018)

Characterization of GSK′963: a structurally distinct, potent and selective inhibitor of RIP1 kinase
por: Berger, SB, et al.
Publicado: (2015)

Toll-Like Receptor (TLR) and Nucleosome-binding Oligomerization Domain (NOD) gene polymorphisms and endometrial cancer risk
por: Ashton, Katie A, et al.
Publicado: (2010)

Nucleotide-binding oligomerization domain 1 and Helicobacter pylori infection: A review
por: Minaga, Kosuke, et al.
Publicado: (2018)

Expression of nucleotide-binding oligomerization domain 1 and 2 in oral lichen planus
por: Ahn, Mee-Young, et al.
Publicado: (2020)

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases
por: Correa, Ricardo G., et al.
Publicado: (2012)

Pathogen Sensing Pathways in Human Embryonic Stem Cell Derived-Endothelial Cells: Role of NOD1 Receptors
por: Reed, Daniel M., et al.
Publicado: (2014)

NOD1/NOD2 signaling links ER stress with inflammation
por: Keestra-Gounder, A. Marijke, et al.
Publicado: (2016)

POTENTIAL ROLE OF A SINGLE NUCLEOTIDE POLYMORPHISM OF NOD-LIKE RECEPTOR-X1 IN COVID-19 SUSCEPTIBILITY
por: DEEPAK, V., et al.
Publicado: (2022)

NOD1 and NOD2 Signaling in Infection and Inflammation
por: Moreira, Lilian O., et al.
Publicado: (2012)

Nucleotide-binding oligomerization domain protein-1 is expressed and involved in the inflammatory response in human sebocytes
por: Kitajima, Natsuko, et al.
Publicado: (2023)

Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators
por: Parkhouse, Rhiannon, et al.
Publicado: (2014)

Mediators of Metabolism: An Unconventional Role for NOD1 and NOD2
por: Zangara, Megan T., et al.
Publicado: (2021)

Geochemical influences on nonenzymatic oligomerization of prebiotically relevant cyclic nucleotides
por: Dagar, Shikha, et al.
Publicado: (2020)

Nucleotide-Binding Oligomerization Domain-1 and -2 Play No Role in Controlling Brucella abortus Infection in Mice
por: Oliveira, Fernanda S., et al.
Publicado: (2012)

NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy
por: Wang, Dongjie
Publicado: (2022)

Activation of NOD1 and NOD2 in the development of liver injury and cancer
por: Omaru, Naoya, et al.
Publicado: (2022)

A Salmonella Virulence Factor Activates the NOD1/NOD2 Signaling Pathway
por: Marijke Keestra, A., et al.
Publicado: (2011)

Nucleotide-binding oligomerization domain 1 is dispensable for host immune responses against pulmonary infection of Acinetobacter baumannii in mice
por: Kang, Min-Jung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gfl4qtqro7l2goc4sbbqa8p2t0